oxandrolone has been researched along with HIV Coinfection in 13 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of oxandrolone in promoting body weight and body cell mass (BCM) gain in HIV-associated weight loss." | 9.12 | Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. ( Bhasin, S; Dobs, A; Glesby, M; Grunfeld, C; Kotler, DP, 2006) |
| " In a randomized trial, we compared the effects of 2 months of treatment with either megestrol acetate (800 mg every day) or oxandrolone (10 mg twice per day) on body weight and composition in patients with weight loss of > or =5 kg who were receiving HAART." | 9.11 | Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months. ( Albrecht, M; Chang, H; Forfia, J; Gerrior, J; Miller, L; Mwamburi, DM; Saboori, S; Scully, E; Wanke, CA; Wilson, IB, 2004) |
| "Men with acquired immunodeficiency syndrome (AIDS) wasting and hypogonadism are frequently treated with testosterone and oxandrolone, an orally administered anabolic-androgenic steroid hormone." | 7.74 | Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone. ( Rubin, D; Segal-Maurer, S; Wasserman, P, 2008) |
| "To evaluate the efficacy and safety of oxandrolone in promoting body weight and body cell mass (BCM) gain in HIV-associated weight loss." | 5.12 | Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. ( Bhasin, S; Dobs, A; Glesby, M; Grunfeld, C; Kotler, DP, 2006) |
| " In a randomized trial, we compared the effects of 2 months of treatment with either megestrol acetate (800 mg every day) or oxandrolone (10 mg twice per day) on body weight and composition in patients with weight loss of > or =5 kg who were receiving HAART." | 5.11 | Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months. ( Albrecht, M; Chang, H; Forfia, J; Gerrior, J; Miller, L; Mwamburi, DM; Saboori, S; Scully, E; Wanke, CA; Wilson, IB, 2004) |
| "Men with acquired immunodeficiency syndrome (AIDS) wasting and hypogonadism are frequently treated with testosterone and oxandrolone, an orally administered anabolic-androgenic steroid hormone." | 3.74 | Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone. ( Rubin, D; Segal-Maurer, S; Wasserman, P, 2008) |
| " Current studies include the effects of protease inhibitors on blood sugar, the effectiveness of twice a day Crixivan dosing, the effectiveness of adefovir dipivoxil in combination with protease inhibitors, the effectiveness of DMP 266 in combination with several drugs, and the effects of Oxandrolone on weight loss in women." | 3.70 | CRIA clinical trials. ( , 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mwamburi, DM | 1 |
| Gerrior, J | 1 |
| Wilson, IB | 1 |
| Chang, H | 1 |
| Scully, E | 1 |
| Saboori, S | 1 |
| Miller, L | 1 |
| Forfia, J | 1 |
| Albrecht, M | 1 |
| Wanke, CA | 1 |
| Grunfeld, C | 1 |
| Kotler, DP | 1 |
| Dobs, A | 1 |
| Glesby, M | 1 |
| Bhasin, S | 1 |
| Wasserman, P | 1 |
| Segal-Maurer, S | 1 |
| Rubin, D | 1 |
| Strawford, A | 1 |
| Barbieri, T | 1 |
| Van Loan, M | 1 |
| Parks, E | 1 |
| Catlin, D | 1 |
| Barton, N | 1 |
| Neese, R | 1 |
| Christiansen, M | 1 |
| King, J | 1 |
| Hellerstein, MK | 1 |
| Earthman, CP | 1 |
| Matthie, JR | 1 |
| Reid, PM | 1 |
| Harper, IT | 1 |
| Ravussin, E | 1 |
| Howell, WH | 1 |
| Romeyn, M | 1 |
| Gunn, N | 1 |
| Berger, JR | 1 |
| Bell, LE | 1 |
| Yarasheski, KE | 1 |
| Roubenoff, R | 1 |
1 review available for oxandrolone and HIV Coinfection
| Article | Year |
|---|---|
Exercise treatment for HIV-associated metabolic and anthropomorphic complications.
Topics: Acquired Immunodeficiency Syndrome; Anabolic Agents; Anthropometry; Antiretroviral Therapy, Highly A | 2001 |
3 trials available for oxandrolone and HIV Coinfection
| Article | Year |
|---|---|
Comparing megestrol acetate therapy with oxandrolone therapy for HIV-related weight loss: similar results in 2 months.
Topics: Adult; Androgens; Antiretroviral Therapy, Highly Active; Body Weight; Female; HIV Infections; Humans | 2004 |
Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Anabolic Agents; Body Mass Index; Double-Blind Method; Follicle Stimulating Hormone; HIV Infe | 2006 |
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
Topics: Adult; Anabolic Agents; Blood Chemical Analysis; Body Composition; Double-Blind Method; Energy Intak | 1999 |
9 other studies available for oxandrolone and HIV Coinfection
| Article | Year |
|---|---|
Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone.
Topics: Adult; Androgens; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Erectile Dysfunc | 2008 |
A comparison of bioimpedance methods for detection of body cell mass change in HIV infection.
Topics: Adult; Anabolic Agents; Body Water; Body Weight; Electric Impedance; Evaluation Studies as Topic; Ex | 2000 |
Resistance exercise and oxandrolone for men with HIV-related weight loss.
Topics: Anabolic Agents; Exercise; Female; HIV Infections; HIV Wasting Syndrome; Humans; Male; Oxandrolone; | 2000 |
Resistance exercise and oxandrolone for men with HIV-related weight loss.
Topics: Anabolic Agents; Exercise; HIV Infections; Humans; Male; Muscle Weakness; Oxandrolone; Weight Loss | 2000 |
Lipodystrophy treatment better with exercise.
Topics: Anabolic Agents; Exercise; HIV Infections; Humans; Lipodystrophy; Oxandrolone; Treatment Outcome | 2000 |
Experts leery of new oral testosterone treatment.
Topics: Administration, Oral; Anabolic Agents; Cachexia; HIV Infections; Humans; Male; Oxandrolone; Testoste | 1996 |
Women, food and HIV.
Topics: Anabolic Agents; Diet; Female; HIV Infections; HIV Wasting Syndrome; Humans; Nutritional Requirement | 1998 |
CRIA clinical trials.
Topics: Adenine; Alkynes; Anabolic Agents; Anti-HIV Agents; Benzoxazines; Blood Glucose; Clinical Trials as | 1998 |
Orphan drug for HIV wasting syndrome.
Topics: Anorexia; HIV Infections; Humans; Oxandrolone; Syndrome; Weight Loss | 1991 |